{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:56:50Z","timestamp":1793073410162,"version":"4.5.0"},"reference-count":205,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The National Neurological Conditions Surveillance System (NNCSS) is congressionally mandated to track the epidemiology of neurological conditions in the United States. Parkinson disease (PD) was selected as an initial condition, but methods for conducting PD surveillance are limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To review evidence for, evaluate the performance of, and select data source types and case definitions for national PD surveillance.<\/jats:p>\n <\/jats:sec>\n \n Evidence Review<\/jats:title>\n Medline, Embase, PsycInfo, CINAHL, and Scopus were searched from January 1980 through November 2023; expert-identified and bibliographically mined references were included. Articles were screened and reviewed for eligibility from April 2020 to May 2024. Eligible articles included case definitions to produce population-based estimates and used data sources appropriate for population-level analyses. Study quality was assessed using Methodological Evaluation of Observational Research and Quality Assessment of Diagnostic Accuracy Studies\u20132. Case definitions and data source types were evaluated using key attributes of public health surveillance systems (hereafter key attributes).<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n A total of 156 articles, published between 2001 and 2023, were included. These articles largely used administrative data (140 [90%]), especially claims (102 [65%]). The 163 included case definitions varied substantially and were allocated into 6 groups along a spectrum according to likely inclusion and\/or exclusion of other parkinsonisms (OP) and resulting misclassification bias. At one end, \u201cPD probable\u201d definitions (15 of 163 [9%]) removed most OP, maximizing specificity but likely missing some PD cases with limited or conflicting claims evidence. Alternatively, \u201cPD possible\u201d definitions (11 of 163 [7%]) captured PD cases with limited or conflicting evidence, maximizing sensitivity but likely including some OP. Case definitions\u2019 performance on key attributes varied widely. Claims performed best on key attributes.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n \n In this systematic review of PD case definitions for national surveillance, no single definition provided a precise estimate due to potential diagnostic uncertainty in PD\u2019s early stages and\n International Classification of Disease<\/jats:italic>\n (\n ICD<\/jats:italic>\n ) coding limitations that preclude definitively distinguishing PD from OP in population-based data sources. The best-performing PD probable and PD possible case definitions were selected to use to establish an estimate range. The probable definition provides high diagnostic certainty of PD. The possible definition avoids missing PD cases with limited or conflicting evidence. This work demonstrated NNCSS\u2019s methods for selecting and reappraising case definitions and data source types, providing a foundation for NNCSS\u2019s PD surveillance and expansion to other neurological conditions.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.13928","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:30:32Z","timestamp":1780932632000},"page":"e2613928","source":"Crossref","is-referenced-by-count":1,"title":["Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance"],"prefix":"10.1001","volume":"9","author":[{"given":"Christine D.","family":"Esper","sequence":"first","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"},{"name":"Guidehouse Inc, Chamblee, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly N.","family":"Hogan","sequence":"additional","affiliation":[{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"},{"name":"Guidehouse Inc, Chamblee, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purni","family":"Abeysekara","sequence":"additional","affiliation":[{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"},{"name":"Alaka\u2019ina Foundation Inc, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey Nichole","family":"Smith","sequence":"additional","affiliation":[{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"},{"name":"4ES, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenbroeck G.","family":"Smith","sequence":"additional","affiliation":[{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"},{"name":"4ES, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna L.","family":"Mercer","sequence":"additional","affiliation":[{"name":"National Neurological Conditions Surveillance System, Inform and Disseminate Division, Office of Public Health Data, Science, and Technology, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"10291","key":"zoi260409r1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease.","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"zoi260409r2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","journal-title":"Lancet Neurol"},{"issue":"4","key":"zoi260409r3","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3233\/JPD-212612","article-title":"The experiences of treatment burden in people with Parkinson\u2019s disease and their caregivers: a systematic review of qualitative studies.","volume":"11","author":"Tan","year":"2021","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"zoi260409r4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/08919887231195219","article-title":"Caregiver burden in Parkinson disease: a scoping review of the literature from 2017-2022.","volume":"37","author":"Aamodt","year":"2024","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"zoi260409r5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease.","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"issue":"10","key":"zoi260409r6","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/mds.27485","article-title":"Importance of low diagnostic accuracy for early Parkinson\u2019s disease.","volume":"33","author":"Beach","year":"2018","journal-title":"Mov Disord"},{"issue":"6","key":"zoi260409r7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis.","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"key":"zoi260409r8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021.","author":"Luo","journal-title":"Front Aging Neurosci"},{"issue":"71","key":"zoi260409r10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"8","key":"zoi260409r12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi260409r13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jclinepi.2010.08.006","article-title":"Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists.","volume":"64","author":"Shamliyan","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"zoi260409r14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fvets.2018.00099","article-title":"Selection and misclassification biases in longitudinal studies.","volume":"5","author":"Haine","year":"2018","journal-title":"Front Vet Sci"},{"issue":"3","key":"zoi260409r15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/ije\/dyac239","article-title":"Quantitative bias analysis of prevalence under misclassification: evaluation indicators, calculation method and case analysis.","volume":"52","author":"Liu","year":"2023","journal-title":"Int J Epidemiol"},{"key":"zoi260409r16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jclinepi.2020.06.039","article-title":"Quality assessment of prevalence studies: a systematic review.","volume":"127","author":"Migliavaca","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"zoi260409r18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-publhealth-031816-044348","article-title":"Public health surveillance systems: recent advances in their use and evaluation.","volume":"38","author":"Groseclose","year":"2017","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"zoi260409r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.su7303a1","article-title":"A standard framework for evaluating large health care data and related resources.","volume":"73","author":"El Burai Felix","year":"2024","journal-title":"MMWR Suppl"},{"issue":"5","key":"zoi260409r20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10072-015-2062-z","article-title":"Reliability of administrative data for the identification of Parkinson\u2019s disease cohorts.","volume":"36","author":"Baldacci","year":"2015","journal-title":"Neurol Sci"},{"issue":"1","key":"zoi260409r21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000365590","article-title":"A validation study of administrative data algorithms to identify patients with Parkinsonism with prevalence and incidence trends.","volume":"43","author":"Butt","year":"2014","journal-title":"Neuroepidemiology"},{"issue":"1","key":"zoi260409r22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JPD-2011-11024","article-title":"Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson\u2019s disease in a large Israeli population.","volume":"1","author":"Chillag-Talmor","year":"2011","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"zoi260409r23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000336356","article-title":"Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.","volume":"38","author":"Feldman","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"7","key":"zoi260409r24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.","volume":"66","author":"Hern\u00e1n","year":"2006","journal-title":"Neurology"},{"key":"zoi260409r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105764","article-title":"Parkinson\u2019s disease diagnosis codes are insufficiently accurate for electronic health record research and differ by race.","volume":"114","author":"Hill","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"zoi260409r26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/aje\/kwu326","article-title":"Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.","volume":"181","author":"Jain","year":"2015","journal-title":"Am J Epidemiol"},{"key":"zoi260409r27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.envint.2016.08.017","article-title":"Traffic-related air pollution increased the risk of Parkinson\u2019s disease in Taiwan: a nationwide study.","volume":"96","author":"Lee","year":"2016","journal-title":"Environ Int"},{"issue":"8756359","key":"zoi260409r28","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8756359","article-title":"Variations in incidence and prevalence of Parkinson\u2019s disease in Taiwan: a population-based nationwide study.","volume":"2016","author":"Liu","year":"2016","journal-title":"Parkinsons Dis"},{"issue":"1","key":"zoi260409r29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12883-023-03361-w","article-title":"Dementia and Parkinson\u2019s disease diagnoses in electronic health records vs. Medicare claims data: a study of 101,980 linked patients.","volume":"23","author":"Lusk","year":"2023","journal-title":"BMC Neurol"},{"issue":"4","key":"zoi260409r30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/mds.21299","article-title":"Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey.","volume":"22","author":"Noyes","year":"2007","journal-title":"Mov Disord"},{"key":"zoi260409r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100061","article-title":"Identifying incident Parkinson\u2019s disease using administrative diagnostic codes: a validation study.","volume":"3","author":"Peterson","year":"2020","journal-title":"Clin Park Relat Disord"},{"issue":"8","key":"zoi260409r32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.29457","article-title":"Lifelong association of disorders related to military trauma with subsequent Parkinson\u2019s disease.","volume":"38","author":"Scott","year":"2023","journal-title":"Mov Disord"},{"issue":"8","key":"zoi260409r33","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/mds.20479","article-title":"Identifying and distinguishing cases of parkinsonism and Parkinson\u2019s disease using ICD-9 CM codes and pharmacy data.","volume":"20","author":"Swarztrauber","year":"2005","journal-title":"Mov Disord"},{"issue":"9","key":"zoi260409r34","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1212\/01.wnl.0000210433.49727.40","article-title":"Initial pharmacotherapy in a population of veterans with Parkinson disease.","volume":"66","author":"Swarztrauber","year":"2006","journal-title":"Neurology"},{"key":"zoi260409r35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fneur.2019.00640","article-title":"Linking individual patient data to estimate incidence and prevalence of Parkinson\u2019s disease by comparing reports of neurological services and pharmacy prescription refills at a nationwide level.","volume":"10","author":"Szatm\u00e1ri","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"zoi260409r36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mds.22283","article-title":"Optimizing algorithms to identify Parkinson\u2019s disease cases within an administrative database.","volume":"24","author":"Szumski","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"zoi260409r37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/mdc3.12318","article-title":"Utility of electronic medical record for recruitment in clinical research: from rare to common disease.","volume":"3","author":"Thacker","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"e1","key":"zoi260409r38","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/jamia\/ocv130","article-title":"Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance.","volume":"23","author":"Wei","year":"2016","journal-title":"J Am Med Inform Assoc"},{"issue":"7","key":"zoi260409r39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/mds.21353","article-title":"Identifying incident cases of parkinsonism among veterans using a tertiary medical center.","volume":"22","author":"White","year":"2007","journal-title":"Mov Disord"},{"issue":"4","key":"zoi260409r40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1370\/afm.1644","article-title":"Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records.","volume":"12","author":"Williamson","year":"2014","journal-title":"Ann Fam Med"},{"issue":"5","key":"zoi260409r41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000533362","article-title":"Validation of administrative health data algorithms for identifying persons with Parkinson\u2019s disease and the 10-year prevalence trend in Bologna, Italy.","volume":"57","author":"Zenesini","year":"2023","journal-title":"Neuroepidemiology"},{"issue":"5","key":"zoi260409r42","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/mds.26147","article-title":"Incidence and prevalence of Parkinson\u2019s disease among Navajo people living in the Navajo nation.","volume":"30","author":"Gordon","year":"2015","journal-title":"Mov Disord"},{"issue":"8","key":"zoi260409r43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/jcm8081118","article-title":"Fibromyalgia-like syndrome associated with Parkinson\u2019s Disease\u2014a cohort study.","volume":"8","author":"Abuhasira","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"zoi260409r44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp.2008.152983","article-title":"Use of antidepressants and the risk of Parkinson\u2019s disease: a prospective study.","volume":"80","author":"Alonso","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"zoi260409r45","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/mdc3.13458","article-title":"Advanced-stage Parkinson\u2019s disease: from identification to characterization using a nationwide database.","volume":"9","author":"Barer","year":"2022","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"zoi260409r46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1468-1331.2010.03176.x","article-title":"Risk of incident depression in patients with Parkinson disease in the UK.","volume":"18","author":"Becker","year":"2011","journal-title":"Eur J Neurol"},{"issue":"5","key":"zoi260409r47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2165\/00002018-200831050-00004","article-title":"Use of statins and the risk of Parkinson\u2019s disease: a retrospective case-control study in the UK.","volume":"31","author":"Becker","year":"2008","journal-title":"Drug Saf"},{"key":"zoi260409r48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40200-015-0209-3","article-title":"Diabetes care among elderly Medicare beneficiaries with Parkinson\u2019s disease and diabetes.","volume":"14","author":"Bhattacharjee","year":"2015","journal-title":"J Diabetes Metab Disord"},{"key":"zoi260409r49","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3402983","article-title":"Patterns and predictors of depression treatment among older adults with Parkinson\u2019s disease and depression in ambulatory care settings in the United States.","volume":"2018","author":"Bhattacharjee","year":"2018","journal-title":"Parkinsons Dis"},{"issue":"3","key":"zoi260409r50","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/ene.12592","article-title":"Parkinson\u2019s disease incidence and prevalence assessment in France using the national healthcare insurance database.","volume":"22","author":"Blin","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1","key":"zoi260409r51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-022-00280-4","article-title":"A nationwide study of the incidence, prevalence and mortality of Parkinson\u2019s disease in the Norwegian population.","volume":"8","author":"Brakedal","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"8","key":"zoi260409r52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/mds.20907","article-title":"Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study.","volume":"21","author":"Brandt-Christensen","year":"2006","journal-title":"Mov Disord"},{"issue":"1","key":"zoi260409r53","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4599","article-title":"Trends in health service use for Canadian adults with dementia and Parkinson disease during the first wave of the COVID-19 pandemic.","volume":"3","author":"Bronskill","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"2","key":"zoi260409r54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246342","article-title":"Representation of Parkinson\u2019s disease and atypical Parkinson\u2019s syndromes in the Czech Republic\u2014a nationwide retrospective study.","volume":"16","author":"B\u00faril","year":"2021","journal-title":"PLoS One"},{"issue":"1-3","key":"zoi260409r55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson\u2019s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.","volume":"120","author":"Callaghan","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"zoi260409r56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2018.02.008","article-title":"Inflammatory bowel disease and risk of Parkinson\u2019s disease in Medicare beneficiaries.","volume":"50","author":"Camacho-Soto","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"zoi260409r57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neurol.2017.03.036","article-title":"Descriptive study of the parkinsonian population in the north of France: epidemiological analysis and healthcare consumption.","volume":"173","author":"Carriere","year":"2017","journal-title":"Rev Neurol (Paris)"},{"issue":"11","key":"zoi260409r58","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40261-019-00830-4","article-title":"Comprehensive real-world assessment of marketed medications to guide Parkinson\u2019s drug discovery.","volume":"39","author":"Cepeda","year":"2019","journal-title":"Clin Drug Investig"},{"issue":"3","key":"zoi260409r59","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/JPD-202190","article-title":"Characteristics of Parkinson\u2019s disease in patients with and without cognitive impairment.","volume":"11","author":"Chandler","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"zoi260409r60","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/NDT.S99365","article-title":"Risk factors for pneumonia among patients with Parkinson\u2019s disease: a Taiwan nationwide population-based study.","volume":"12","author":"Chang","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"zoi260409r61","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.sapharm.2015.09.007","article-title":"Quality of life of patients with Parkinson\u2019s disease and neurodegenerative dementia: a nationally representative study.","volume":"12","author":"Chekani","year":"2016","journal-title":"Res Social Adm Pharm"},{"issue":"10","key":"zoi260409r62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jagp.2020.01.193","article-title":"Risk of mortality associated with atypical antipsychotic use: a national cohort study of older adults with depression and Parkinson\u2019s disease.","volume":"28","author":"Chekani","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"zoi260409r63","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.parkreldis.2012.01.014","article-title":"Parkinson\u2019s disease and risk of hip fracture: an 8-year follow-up study in Taiwan.","volume":"18","author":"Chen","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"zoi260409r64","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/jsr.12289","article-title":"Obstructive sleep apnea and risk of Parkinson\u2019s disease: a population-based cohort study.","volume":"24","author":"Chen","year":"2015","journal-title":"J Sleep Res"},{"issue":"8","key":"zoi260409r65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182834","article-title":"Long-term exposure to air pollution and the incidence of Parkinson\u2019s disease: a nested case-control study.","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"10070","key":"zoi260409r66","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0140-6736(16)32399-6","article-title":"Living near major roads and the incidence of dementia, Parkinson\u2019s disease, and multiple sclerosis: a population-based cohort study.","volume":"389","author":"Chen","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"zoi260409r67","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/ijerph15081587","article-title":"Dental scaling decreases the risk of Parkinson\u2019s disease: a nationwide population-based nested case-control study.","volume":"15","author":"Chen","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"zoi260409r68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2020.04.001","article-title":"Risk of Parkinson\u2019s disease in patients with hypothyroidism: a nationwide population-based cohort study.","volume":"74","author":"Chen","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"zoi260409r69","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/phar.2383","article-title":"Effects of \u00df2-adrenergic agonists on risk of Parkinson\u2019s disease in COPD: a population-based study.","volume":"40","author":"Chen","year":"2020","journal-title":"Pharmacotherapy"},{"key":"zoi260409r70","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.679092","article-title":"Retinal diseases and Parkinson disease: a population-based study.","author":"Chen","journal-title":"Front Neurosci"},{"issue":"9","key":"zoi260409r71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029776","article-title":"Mortality and cause of death in South Korean patients with Parkinson\u2019s disease: a longitudinal follow-up study using a national sample cohort.","volume":"9","author":"Choi","year":"2019","journal-title":"BMJ Open"},{"key":"zoi260409r72","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/NDT.S134311","article-title":"Sleep apnea and the subsequent risk of Parkinson\u2019s disease: a 3-year nationwide population-based study.","volume":"13","author":"Chou","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"zoi260409r73","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/aje\/kwv109","article-title":"Thiazolidinediones and Parkinson disease: a cohort study.","volume":"182","author":"Connolly","year":"2015","journal-title":"Am J Epidemiol"},{"key":"zoi260409r74","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.03.026","article-title":"Urate and the risk of Parkinson\u2019s disease in men and women.","volume":"52","author":"Cortese","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"zoi260409r75","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00228-015-1881-4","article-title":"Trends in inpatient antiparkinson drug use in the USA, 2001-2012.","volume":"71","author":"Crispo","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"zoi260409r76","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1017\/cjn.2020.79","article-title":"Disparities in deep brain stimulation use for Parkinson\u2019s disease in Ontario, Canada.","volume":"47","author":"Crispo","year":"2020","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"zoi260409r77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150621","article-title":"Associations between anticholinergic burden and adverse health outcomes in Parkinson disease.","volume":"11","author":"Crispo","year":"2016","journal-title":"PLoS One"},{"key":"zoi260409r78","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100046","article-title":"Use of a medication-based algorithm to identify advanced Parkinson\u2019s disease in administrative claims data: associations with claims-based indicators of disease severity.","author":"Dahodwala","journal-title":"Clin Park Relat Disord"},{"issue":"8","key":"zoi260409r79","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mds.22557","article-title":"Racial differences in the diagnosis of Parkinson\u2019s disease.","volume":"24","author":"Dahodwala","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"zoi260409r80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/mdc3.12422","article-title":"Prevalence and correlates of anti-Parkinson drug use in a nationally representative sample.","volume":"4","author":"Dahodwala","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"10","key":"zoi260409r81","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1111\/ene.16000","article-title":"Falling incidence of Parkinson\u2019s disease in Germany.","volume":"30","author":"Dammertz","year":"2023","journal-title":"Eur J Neurol"},{"issue":"29","key":"zoi260409r82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1472-6963-14-29","article-title":"Prevalence of neurological conditions across the continuum of care based on interRAI assessments.","volume":"14","author":"Danila","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"zoi260409r83","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/art.24193","article-title":"Gout and the risk of Parkinson\u2019s disease: a cohort study.","volume":"59","author":"De Vera","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"zoi260409r84","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/08919887231163293","article-title":"Anxiety in Parkinson\u2019s patients: what\u2019s timing got to do with it?","volume":"36","author":"DeMarco","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"7","key":"zoi260409r85","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/jgs.15460","article-title":"Prevalence of morbidity at extreme old age in Germany: an observational study using health claims data.","volume":"66","author":"Doblhammer","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"zoi260409r86","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/mds.22679","article-title":"Atypical antipsychotic use and risk of fracture in persons with Parkinsonism.","volume":"24","author":"Dore","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"zoi260409r87","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jocn.2007.02.095","article-title":"Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.","volume":"15","author":"Etminan","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"8","key":"zoi260409r88","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10072-019-03872-w","article-title":"Incidence and prevalence of Parkinson\u2019s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases.","volume":"40","author":"Eusebi","year":"2019","journal-title":"Neurol Sci"},{"key":"zoi260409r89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.parkreldis.2019.02.013","article-title":"Transplant and risk of Parkinson disease.","volume":"63","author":"Fan","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"zoi260409r90","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8493916","article-title":"Risk of dementia in patients with depression or Parkinson\u2019s disease: a retrospective cohort study.","volume":"2020","author":"Fang","year":"2020","journal-title":"Parkinsons Dis"},{"key":"zoi260409r91","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2857608","article-title":"Validation of a Parkinson disease predictive model in a population-based study.","volume":"2020","author":"Faust","year":"2020","journal-title":"Parkinsons Dis"},{"issue":"9","key":"zoi260409r92","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.parkreldis.2011.06.009","article-title":"Occupational exposure in parkinsonian disorders: a 43-year prospective cohort study in men.","volume":"17","author":"Feldman","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"zoi260409r93","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.envres.2007.03.002","article-title":"A study of the relationships between Parkinson\u2019s disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities.","volume":"104","author":"Finkelstein","year":"2007","journal-title":"Environ Res"},{"issue":"5","key":"zoi260409r94","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13696998.2017.1284668","article-title":"Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson\u2019s disease.","volume":"20","author":"Fran\u00e7ois","year":"2017","journal-title":"J Med Econ"},{"issue":"3","key":"zoi260409r95","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/ije\/dyw016","article-title":"Associations between cancer and Parkinson\u2019s disease in U.S. elderly adults.","volume":"45","author":"Freedman","year":"2016","journal-title":"Int J Epidemiol"},{"key":"zoi260409r96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.12.012","article-title":"Sex disparities in health and health care utilization after Parkinson diagnosis: rethinking PD associated disability.","volume":"48","author":"Fullard","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"zoi260409r97","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1212\/WNL.0000000000012290","article-title":"Health care resource utilization associated with Parkinson disease among Medicare beneficiaries.","volume":"97","author":"Gandhi","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"zoi260409r98","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/mds.25153","article-title":"Parkinson\u2019s disease among American Indians and Alaska natives: a nationwide prevalence study.","volume":"27","author":"Gordon","year":"2012","journal-title":"Mov Disord"},{"issue":"2","key":"zoi260409r99","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JPD-120158","article-title":"Prevalence of Parkinson disease among the Navajo: a preliminary examination.","volume":"3","author":"Gordon","year":"2013","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"zoi260409r100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107465","article-title":"Initial medication in patients of newly diagnosed Parkinson\u2019s disease in Taiwan.","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"zoi260409r101","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.10333","article-title":"Burden of parkinsonism: a population-based study.","volume":"18","author":"Guttman","year":"2003","journal-title":"Mov Disord"},{"issue":"1","key":"zoi260409r102","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1186\/s12889-019-7664-6","article-title":"Prevalence and incidence of Parkinson\u2019s disease and drug-induced parkinsonism in Korea.","volume":"19","author":"Han","year":"2019","journal-title":"BMC Public Health"},{"key":"zoi260409r103","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00500","article-title":"Do we need to rethink the epidemiology and healthcare utilization of Parkinson\u2019s disease in Germany?","author":"Heinzel","journal-title":"Front Neurol"},{"issue":"1","key":"zoi260409r104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1176\/jnp.2010.22.1.105","article-title":"Prevalence of Parkinson\u2019s disease-induced psychosis in a large U.S. managed care population.","volume":"22","author":"Holt","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"zoi260409r105","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00415-012-6804-z","article-title":"Time trends in incidence of Parkinson\u2019s disease diagnosis in UK primary care.","volume":"260","author":"Horsfall","year":"2013","journal-title":"J Neurol"},{"issue":"11","key":"zoi260409r106","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/mds.20609","article-title":"Burden of illness in Parkinson\u2019s disease.","volume":"20","author":"Huse","year":"2005","journal-title":"Mov Disord"},{"key":"zoi260409r107","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jocn.2020.04.009","article-title":"Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson\u2019s disease: a retrospective observational study using administrative claims data.","volume":"76","author":"Iketani","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"7","key":"zoi260409r108","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.27681","article-title":"Association of statin use with Parkinson\u2019s disease: dose-response relationship.","volume":"34","author":"Jeong","year":"2019","journal-title":"Mov Disord"},{"issue":"6","key":"zoi260409r109","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/11596900-000000000-00000","article-title":"Early retirement and income loss in patients with early and advanced Parkinson\u2019s disease.","volume":"9","author":"Johnson","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"zoi260409r110","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.parkreldis.2011.11.018","article-title":"Incidence and mortality of Parkinson\u2019s disease in older Canadians.","volume":"18","author":"Allyson Jones","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"zoi260409r111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10654-017-0229-z","article-title":"Agricultural activities and the incidence of Parkinson\u2019s disease in the general French population.","volume":"32","author":"Kab","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"zoi260409r112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225723","article-title":"The characteristics and treatment patterns of patients with Parkinson\u2019s disease in the United States and United Kingdom: a retrospective cohort study.","volume":"14","author":"Kalilani","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"zoi260409r113","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.parkreldis.2011.11.015","article-title":"Direct costs and survival of Medicare beneficiaries with early and advanced Parkinson\u2019s disease.","volume":"18","author":"Kaltenboeck","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"zoi260409r114","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00415-019-09360-7","article-title":"Real-world pharmacological treatment patterns of patients with young-onset Parkinson\u2019s disease in Japan: a medical claims database analysis.","volume":"266","author":"Kasamo","year":"2019","journal-title":"J Neurol"},{"key":"zoi260409r115","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2021.08.016","article-title":"Racial and geographic disparities with gastrostomy tube placement in dementia and parkinsonian disorders.","volume":"91","author":"Kim","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"zoi260409r116","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1136\/gutjnl-2023-329685","article-title":"Gastrointestinal syndromes preceding a diagnosis of Parkinson\u2019s disease: testing Braak\u2019s hypothesis using a nationwide database for comparison with Alzheimer\u2019s disease and cerebrovascular diseases.","volume":"72","author":"Konings","year":"2023","journal-title":"Gut"},{"issue":"3","key":"zoi260409r117","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/brainsci13030450","article-title":"Association between antiepileptic drugs and incident Parkinson\u2019s disease among patients followed in German primary care practices.","volume":"13","author":"Kostev","year":"2023","journal-title":"Brain Sci"},{"issue":"3","key":"zoi260409r118","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States.","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov Disord"},{"issue":"21","key":"zoi260409r119","doi-asserted-by":"publisher","first-page":"e2058","DOI":"10.1212\/WNL.0000000000207871","article-title":"Fine particulate matter and Parkinson disease risk among Medicare beneficiaries.","volume":"101","author":"Krzyzanowski","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"zoi260409r120","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1210\/jc.2017-02774","article-title":"Association between diabetic retinopathy and Parkinson disease: the Korean National Health Insurance Service Database.","volume":"103","author":"Lee","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi260409r121","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3988\/jcn.2018.14.4.478","article-title":"Region-based analysis of prevalence and incidence of Parkinson\u2019s disease: analysis of the National Sample Cohort in South Korea.","volume":"14","author":"Lee","year":"2018","journal-title":"J Clin Neurol"},{"issue":"7","key":"zoi260409r122","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/j.pain.0000000000000904","article-title":"Parkinson disease and musculoskeletal pain: an 8-year population-based cohort study.","volume":"158","author":"Lien","year":"2017","journal-title":"Pain"},{"issue":"4","key":"zoi260409r123","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.24751","article-title":"Statin therapy prevents the onset of Parkinson disease in patients with diabetes.","volume":"80","author":"Lin","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"zoi260409r124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193783","article-title":"Increased risk of overactive bladder in patients with idiopathic Parkinson\u2019s disease: insight from a nationwide population-based cohort study.","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"zoi260409r125","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jamaneurol.2019.1368","article-title":"Association of antiviral therapy with risk of Parkinson disease in patients with chronic hepatitis C virus infection.","volume":"76","author":"Lin","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"zoi260409r126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152841","article-title":"Early-life factors and risk of Parkinson\u2019s disease: a register-based cohort study.","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"zoi260409r127","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jfma.2015.05.014","article-title":"Time trends in the prevalence and incidence of Parkinson\u2019s disease in Taiwan: a nationwide, population-based study.","volume":"115","author":"Liu","year":"2016","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"zoi260409r128","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate Parkinson\u2019s disease: insight gained from a large, national claims database.","volume":"32","author":"Liu","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"zoi260409r129","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jech.2008.084954","article-title":"Socioeconomic variations in the prevalence and incidence of Parkinson\u2019s disease: a population-based analysis.","volume":"64","author":"Lix","year":"2010","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"zoi260409r130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285585","article-title":"Trends in health service use among persons with Parkinson\u2019s disease by rurality: a population-based repeated cross-sectional study.","volume":"18","author":"Maclagan","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"zoi260409r131","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/gim.2014.70","article-title":"Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.","volume":"17","author":"Madubata","year":"2015","journal-title":"Genet Med"},{"key":"zoi260409r132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0074-8","article-title":"State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.","volume":"5","author":"Mantri","year":"2019","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"zoi260409r133","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab277","article-title":"Incidence of neurological and psychiatric comorbidity over time: a population-based cohort study in Ontario, Canada.","volume":"51","author":"Maxwell","year":"2022","journal-title":"Age Ageing"},{"issue":"3","key":"zoi260409r134","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/aje\/kwr081","article-title":"Prediction model of Parkinson\u2019s disease based on antiparkinsonian drug claims.","volume":"174","author":"Moisan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"9","key":"zoi260409r135","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","article-title":"Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.","volume":"87","author":"Moisan","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"zoi260409r136","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.puhe.2016.12.024","article-title":"Coding accuracy for Parkinson\u2019s disease hospital admissions: implications for healthcare planning in the UK.","volume":"146","author":"Muzerengi","year":"2017","journal-title":"Public Health"},{"issue":"5","key":"zoi260409r137","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/ane.12694","article-title":"Parkinson\u2019s disease in Germany: prevalence and incidence based on health claims data.","volume":"136","author":"Nerius","year":"2017","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"zoi260409r138","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1002\/mds.28727","article-title":"Mortality of people with Parkinson\u2019s disease in a large UK-based cohort study: time trends and relationship to disease duration.","volume":"36","author":"Okunoye","year":"2021","journal-title":"Mov Disord"},{"issue":"1","key":"zoi260409r139","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-022-00284-0","article-title":"Change in the incidence of Parkinson\u2019s disease in a large UK primary care database.","volume":"8","author":"Okunoye","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"zoi260409r140","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.2147\/NDT.S325521","article-title":"Impact of antidepressants on cardiac events and all-cause mortality in Parkinson\u2019s disease: a national data-linkage study.","volume":"17","author":"Orayj","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"zoi260409r141","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41531-023-00523-y","article-title":"Care access and utilization among Medicare beneficiaries living with Parkinson\u2019s disease.","volume":"9","author":"Pearson","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"zoi260409r142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105402","article-title":"Risk of Parkinson\u2019s disease in a gout Mediterranean population: a case-control study.","volume":"89","author":"Pou","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"6","key":"zoi260409r143","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/14737167.2020.1681266","article-title":"Direct cost of Parkinson\u2019s disease in a health system with high judicialization: evidence from Colombia.","volume":"20","author":"Prada","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"zoi260409r144","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000448402","article-title":"Epidemiology of Parkinson\u2019s disease: a population-based study in primary care in Italy.","volume":"47","author":"Pupillo","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"4","key":"zoi260409r145","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40258-013-0033-1","article-title":"Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson\u2019s disease: a retrospective claims database analysis.","volume":"11","author":"Richy","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"zoi260409r146","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/gps.4414","article-title":"Estimating the prevalence of Parkinson\u2019s disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data.","volume":"31","author":"Riedel","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"zoi260409r147","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s41669-021-00321-3","article-title":"Prevalence and cost of care for Parkinson\u2019s disease in Luxembourg: an analysis of national healthcare insurance data.","volume":"6","author":"Schmitz","year":"2022","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"zoi260409r148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study.","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"issue":"14","key":"zoi260409r149","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1212\/WNL.0000000000004536","article-title":"A predictive model to identify Parkinson disease from administrative claims data.","volume":"89","author":"Searles Nielsen","year":"2017","journal-title":"Neurology"},{"key":"zoi260409r150","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1162016","article-title":"Prescribing patterns and determinants for elderly patients with Parkinson\u2019s disease in Japan: a retrospective observational study using insurance claims databases.","volume":"14","author":"Seki","year":"2023","journal-title":"Front Neurol"},{"issue":"8","key":"zoi260409r151","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jamda.2020.11.021","article-title":"Ten-year relative survival from the diagnosis of Parkinson\u2019s disease: a nationwide database study.","volume":"22","author":"Seo","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"zoi260409r152","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/ije\/dyy172","article-title":"Effects of ambient air pollution on incident Parkinson\u2019s disease in Ontario, 2001 to 2013: a population-based cohort study.","volume":"47","author":"Shin","year":"2018","journal-title":"Int J Epidemiol"},{"key":"zoi260409r153","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2147\/CEOR.S422023","article-title":"Treatment patterns and healthcare resource use in Medicare beneficiaries with Parkinson\u2019s disease.","volume":"15","author":"Song","year":"2023","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"zoi260409r154","first-page":"248","article-title":"Parkinson disease hospitalizations and mortality in Louisiana, 1999-2012.","volume":"167","author":"Straif-Bourgeois","year":"2015","journal-title":"J La State Med Soc"},{"issue":"4","key":"zoi260409r155","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000319895","article-title":"Post hoc Parkinson\u2019s disease: identifying an uncommon disease in the Cardiovascular Health Study.","volume":"35","author":"Ton","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"4","key":"zoi260409r156","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10072-018-3273-x","article-title":"The epidemiology of Parkinson\u2019s disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data.","volume":"39","author":"Valent","year":"2018","journal-title":"Neurol Sci"},{"issue":"11","key":"zoi260409r157","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity.","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"6","key":"zoi260409r158","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/pds.624","article-title":"Estimation of incidence and prevalence of Parkinson\u2019s disease in the elderly using pharmacy records.","volume":"10","author":"van de Vijver","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"zoi260409r159","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10654-018-0399-3","article-title":"Association of Parkinson\u2019s disease with industry sectors: a French nationwide incidence study.","volume":"33","author":"Vlaar","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"zoi260409r160","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/ncn3.12689","article-title":"Non-ergot dopamine agonist therapy for Parkinson\u2019s disease in Japan: a claims database analysis.","volume":"11","author":"Wada-Isoe","year":"2023","journal-title":"Neurol Clin Neurosci"},{"issue":"9","key":"zoi260409r161","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.23719","article-title":"Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson\u2019s disease.","volume":"26","author":"Wang","year":"2011","journal-title":"Mov Disord"},{"issue":"10","key":"zoi260409r162","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.clinthera.2013.09.001","article-title":"Antiparkinson drug use and adherence in Medicare part D beneficiaries with Parkinson\u2019s disease.","volume":"35","author":"Wei","year":"2013","journal-title":"Clin Ther"},{"issue":"1","key":"zoi260409r163","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2014.10.021","article-title":"Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures.","volume":"21","author":"Wei","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"zoi260409r164","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ibd\/izy190","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: a nationwide Swedish cohort study.","volume":"25","author":"Weimers","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"zoi260409r165","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaneurol.2016.0031","article-title":"Association of antipsychotic use with mortality risk in patients with Parkinson disease.","volume":"73","author":"Weintraub","year":"2016","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi260409r166","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/mds.27302","article-title":"Short- and long-term cost and utilization of health care resources in Parkinson\u2019s disease in the UK.","volume":"33","author":"Weir","year":"2018","journal-title":"Mov Disord"},{"key":"zoi260409r167","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.parkreldis.2019.10.018","article-title":"Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: Retrospective cohort study.","volume":"68","author":"Wetmore","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"zoi260409r168","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.","volume":"34","author":"Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"9","key":"zoi260409r169","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/WNL.0b013e31822c9123","article-title":"Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.","volume":"77","author":"Willis","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"zoi260409r170","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000527537","article-title":"Association of dietary patterns with Parkinson\u2019s disease: a cross-sectional study based on the United States National Health and Nutritional Examination Survey database.","volume":"86","author":"Xu","year":"2023","journal-title":"Eur Neurol"},{"issue":"3","key":"zoi260409r171","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005921","article-title":"Increased risk of Parkinson disease with diabetes mellitus in a population-based study.","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"zoi260409r172","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12940-020-0565-4","article-title":"Road proximity, air pollution, noise, green space and neurologic disease incidence: a population-based cohort study.","volume":"19","author":"Yuchi","year":"2020","journal-title":"Environ Health"},{"issue":"3","key":"zoi260409r173","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/JNN.0000000000000582","article-title":"Hospital magnet status associates with inpatient safety in Parkinson disease.","volume":"53","author":"Aamodt","year":"2021","journal-title":"J Neurosci Nurs"},{"key":"zoi260409r174","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1254969","article-title":"Unique characteristics of end-of-life hospitalizations in Parkinson disease.","author":"Aamodt","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"zoi260409r175","doi-asserted-by":"publisher","first-page":"405","DOI":"10.18553\/jmcp.2022.28.4.405","article-title":"The economic burden of Parkinson disease among Medicare beneficiaries.","volume":"28","author":"Albarmawi","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"zoi260409r178","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"zoi260409r179","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2023.1149154","article-title":"Parkinson\u2019s disease population-wide registries in the United States: current and future opportunities.","volume":"5","author":"Wu","year":"2023","journal-title":"Front Digit Health"},{"issue":"9","key":"zoi260409r180","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1007\/s00415-018-8969-6","article-title":"The accuracy of the clinical diagnosis of Parkinson disease: the HUNT study.","volume":"265","author":"Hustad","year":"2018","journal-title":"J Neurol"},{"issue":"7","key":"zoi260409r181","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","article-title":"Epidemiology and economic burden of Lewy body dementia in the United States.","volume":"38","author":"Desai","year":"2022","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"zoi260409r182","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","article-title":"Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"zoi260409r183","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/mds.26839","article-title":"Incidence and time trends of drug-induced parkinsonism: a 30-year population-based study.","volume":"32","author":"Savica","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"zoi260409r184","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","article-title":"Vascular parkinsonism\u2014characteristics, pathogenesis and treatment.","volume":"11","author":"Korczyn","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"zoi260409r186","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jalz.2016.04.002","article-title":"Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.","volume":"13","author":"Goodman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"zoi260409r187","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105285","article-title":"Sex differences in dementia with Lewy bodies: focused review of available evidence and future directions.","volume":"107","author":"Chiu","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"zoi260409r188","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-444-64012-3.00009-5","article-title":"Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.","volume":"165","author":"Fabbrini","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"zoi260409r189","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/tcmj.tcmj_218_20","article-title":"Epidemiology of atypical parkinsonian syndromes.","volume":"34","author":"Lo","year":"2021","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"zoi260409r190","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14802\/jmd.20034","article-title":"The Queensland Parkinson\u2019s Project: an overview of 20 years of mortality from Parkinson\u2019s disease.","volume":"14","author":"Poortvliet","year":"2021","journal-title":"J Mov Disord"},{"issue":"2","key":"zoi260409r191","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018969","article-title":"Mortality and quality of death certification in a cohort of patients with Parkinson\u2019s disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.","volume":"8","author":"Hobson","year":"2018","journal-title":"BMJ Open"},{"key":"zoi260409r192","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2017.05.022","article-title":"Death certificate data and causes of death in patients with parkinsonism.","volume":"41","author":"Moscovich","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"zoi260409r193","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00415-020-10113-0","article-title":"Accuracy of death certificates for recording parkinsonian syndromes and associated dementia.","volume":"268","author":"Shi","year":"2021","journal-title":"J Neurol"},{"issue":"3","key":"zoi260409r194","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mds.20339","article-title":"Disparities in the recording of Parkinson\u2019s disease on death certificates.","volume":"20","author":"Pressley","year":"2005","journal-title":"Mov Disord"},{"issue":"6","key":"zoi260409r195","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.parkreldis.2011.04.007","article-title":"Ongoing challenges to finding people with Parkinson\u2019s disease for epidemiological studies: a comparison of population-level case ascertainment methods.","volume":"17","author":"Harris","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"zoi260409r198","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/pds.3438","article-title":"Automatic generation of case-detection algorithms to identify children with asthma from large electronic health record databases.","volume":"22","author":"Afzal","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"zoi260409r199","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pai.12376","article-title":"Time trends in the incidence, prevalence and age at diagnosis of asthma in children.","volume":"26","author":"Engelkes","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"zoi260409r200","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0895-4356(99)00183-3","article-title":"Coronary heart disease surveillance: field application of an epidemiologic algorithm.","volume":"53","author":"Assaf","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi260409r201","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1464-5491.2009.02917.x","article-title":"A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data.","volume":"27","author":"de Lusignan","year":"2010","journal-title":"Diabet Med"},{"issue":"12","key":"zoi260409r202","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10654-019-00558-7","article-title":"Validation of multiple sclerosis diagnoses in the Swedish National Patient Register.","volume":"34","author":"Murley","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"zoi260409r203","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rmed.2017.10.024","article-title":"The prevalence of COPD in England: an ontological approach to case detection in primary care.","volume":"132","author":"Rayner","year":"2017","journal-title":"Respir Med"},{"issue":"2","key":"zoi260409r204","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/mds.29683","article-title":"A statement of the MDS on Biological Definition, Staging, and Classification of Parkinson\u2019s Disease.","volume":"39","author":"Cardoso","year":"2024","journal-title":"Mov Disord"},{"issue":"10","key":"zoi260409r205","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.30007","article-title":"International Parkinson and Movement Disorder Society viewpoint on biological frameworks of Parkinson\u2019s Disease: current status and future directions.","volume":"39","author":"Kalia","year":"2024","journal-title":"Mov Disord"},{"key":"zoi260409r196","author":"Centers for Disease Control and Prevention"},{"key":"zoi260409r9","unstructured":"21st Century Cures Act, Pub. L. No. 114-255, 114th Cong, Sec. 2061. National Neurological Conditions Surveillance System, 114-225 130 STAT. 1033 44-47 \u00a72061 (2016). Accessed April 21, 2026. https:\/\/www.congress.gov\/114\/plaws\/publ255\/PLAW-114publ255.pdf"},{"key":"zoi260409r11","unstructured":"Covidence systematic review software. Accessed April 21, 2026. www.covidence.org"},{"key":"zoi260409r17","unstructured":"Sterne? JAC, Hern\u00e1n? MA, McAleenan? A, Reeves? BC, Higgins? JPT. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 6.3. Cochrane; 2022. Accessed April 14, 2026. https:\/\/training.cochrane.org\/handbook\/current\/chapter-25"},{"key":"zoi260409r176","unstructured":"SNOMED International. Mapping Tool. Accessed October 15, 2022. https:\/\/mapping.ihtsdotools.org\/#\/project\/records?refSetId=P447562003"},{"key":"zoi260409r177","unstructured":"World Health Organization. Extrapyramidal and movement disorders (G20-G26). ICD-10 Version:2019. Accessed October 15, 2022. https:\/\/icd.who.int\/browse10\/2019\/en#\/G20-G26"},{"key":"zoi260409r185","unstructured":"Institute for Health Metrics and Evaluation. GBD Compare. Accessed October 15, 2022. http:\/\/vizhub.healthdata.org\/gbd-compare"},{"key":"zoi260409r197","unstructured":"Centers for Disease Control and Prevention. About NCHS data linkage. Accessed May 5, 2026. https:\/\/www.cdc.gov\/nchs\/linked-data\/about\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2849960\/esper_2026_oi_260409_1780084507.78592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:30:42Z","timestamp":1780932642000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2849960"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":205,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.13928","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}